Talkspace, Inc.TALK

Talkspace’s latest 10-Q shows the company generated $61.7 million in revenue for the three months ending 31 March 2026, but still managed to post a $6.3 million net loss and burn $4.4 million in operating cash. The filing’s headline numbers read like a therapy session for shareholders: revenue up, losses steady, and cash trickling out the door. The company’s cash and equivalents stood at $31.4 million on 31 March 2026, a figure that looks less like a war chest and more like a polite buffer against immediate insolvency. Meanwhile, accounts receivable ballooned to $23.6 million, with $11.5 million owed by enterprise customers and $12.1 million tied to commercial and government payors. Translation: Talkspace is lending more money to its customers than it is collecting, and the customers are in no hurry to pay it back.

Talkspace operates an online therapy and psychiatry platform that connects users with licensed providers for depression, postpartum depression, and other mental health services. The company claims insurance acceptance and positions itself as a convenient, evidence-based alternative to in-person care. Its press page highlights coverage from CNN, The Wall Street Journal, and Glamour, and the platform recently introduced Tee, an AI mental health guide designed to steer users toward licensed professionals. The product story is slick, but the financial reality is less so: the 2025 10-K reveals that four customers each accounted for at least 10% of revenue, underscoring the company’s reliance on a handful of large contracts that could vanish as quickly as a New Year’s resolution.

For the year ended 31 December 2025, Talkspace reported $228.9 million in revenue, up from $187.6 million in 2024, but the growth came with a side of concentration risk and a net loss of $31.6 million. The 10-Q for Q1 2026 lists operating loss at $7.1 million, R&D spend at $2.7 million, and diluted EPS at -$0.04 on 167.1 million shares. The company’s stockholders’ equity stands at $113.1 million, but that number is propped up by goodwill and intangibles rather than consistent profitability. The filing also notes that all revenue in Q1 2026 originated from U.S.-based customers, which is fine until U.S. healthcare policy or reimbursement rules shift without warning.

The company’s market story is built on the promise of scalable, insured mental healthcare delivered via an app, but the evidence shows a business that is still scaling losses faster than it is scaling revenue per user. The polished pitch-depression treatment in a day, postpartum care in a week, AI guides in every chat-reads like a tech-bro manifesto, while the balance sheet reads like a reminder that therapy, whether digital or in-person, still costs more to deliver than most patients or payors are willing to pay upfront. The gap between the product narrative and the financial reality is the real elephant in the room: it’s not the patients, it’s the unit economics.

If you’re looking for a chart route, Talkspace trades on the OTCQB under the symbol TALK and can be tracked via the OTC Markets data feed or your broker’s platform. The stock’s liquidity is thin, and the absence of institutional depth means the tape is more likely to reflect a single large order than a true market. For context, the company’s 52-week volume rarely breaks six figures, and the share price has been range-bound between $0.50 and $1.20 for most of 2026. That’s not a market; it’s a whisper network with a ticker.

The filing evidence does not parse gross margins, customer lifetime value, churn, or unit economics, so any claim about those metrics is speculation. The 10-K and 10-Q do not disclose the number of active users, average revenue per user, or the percentage of revenue derived from insurance reimbursements versus direct consumer payments. The company’s press releases and product pages do not supply these numbers either, which means investors are flying blind on the unit economics that ultimately decide whether this platform is a service or a charity. Until Talkspace publishes hard numbers on utilisation, retention, and reimbursement rates, the financial story remains incomplete.